- Home
- DAKT vs MPLT Comparison
DAKT vs MPLT Comparison
Compare DAKT & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAKT | MPLT |
|---|---|---|
| Founded | 1968 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.1M | 822.2M |
| IPO Year | 1994 | 2025 |
Fundamental Metrics
Financial Performance| Metric | DAKT | MPLT |
|---|---|---|
| Price | $20.49 | $17.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $26.00 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 612.6K | 378.8K |
| Earning Date | 12-10-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $770,283,000.00 | N/A |
| Revenue This Year | $13.76 | N/A |
| Revenue Next Year | $7.35 | N/A |
| P/E Ratio | $138.94 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.24 | $12.24 |
| 52 Week High | $24.38 | $21.55 |
Technical Indicators
Market Signals| Indicator | DAKT | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 63.49 | N/A |
| Support Level | $19.48 | N/A |
| Resistance Level | $19.08 | N/A |
| Average True Range (ATR) | 0.64 | 0.00 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 96.72 | 0.00 |
Price Performance
Historical ComparisonAbout DAKT Daktronics Inc.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.
About MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.